Literature DB >> 25978740

Assessing change in core autism symptoms: challenges for pharmacological studies.

Michael G Aman1, L Eugene Arnold, Jill A Hollway.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25978740     DOI： 10.1089/cap.2015.28999.mga

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  4 in total

Review 1.  Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.

Authors:  Oliver D Howes; Maria Rogdaki; James L Findon; Robert H Wichers; Tony Charman; Bryan H King; Eva Loth; Gráinne M McAlonan; James T McCracken; Jeremy R Parr; Carol Povey; Paramala Santosh; Simon Wallace; Emily Simonoff; Declan G Murphy
Journal:  J Psychopharmacol       Date:  2017-12-14       Impact factor: 4.153

2.  Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder.

Authors:  Abi Bangerter; Seth Ness; Michael G Aman; Anna J Esbensen; Matthew S Goodwin; Geraldine Dawson; Robert Hendren; Bennett Leventhal; Anzalee Khan; Mark Opler; Adrianne Harris; Gahan Pandina
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-05-12       Impact factor: 2.576

3.  Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder.

Authors:  Abigail Bangerter; Seth Ness; David Lewin; Michael G Aman; Anna J Esbensen; Matthew S Goodwin; Geraldine Dawson; Robert Hendren; Bennett Leventhal; Fred Shic; Mark Opler; Kai Fai Ho; Gahan Pandina
Journal:  J Autism Dev Disord       Date:  2020-06

4.  Qualitative evaluation of the Autism Behavior Inventory: use of cognitive interviewing to establish validity of a caregiver report scale for autism spectrum disorder.

Authors:  Gahan Pandina; Seth Ness; Jeremiah Trudeau; Sonja Stringer; Naomi Knoble; William R Lenderking; Abigail Bangerter
Journal:  Health Qual Life Outcomes       Date:  2021-01-20       Impact factor: 3.186
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.